On Monday, a new U.K. study found that a small amount of COVID-19 medication, which was approved in Britain for adults aged between 19 and 50, has shown a significant positive impact on reducing the risk of heart attack and stroke among people with existing heart disease.
The new study, published in the Lancet, found that participants in the study who took a daily dose of the medication between March and October 2016 saw an average of 8.9 percent fewer heart attacks and 8.5 percent fewer strokes, compared to those who took the medication before the study started.
The study was led by the National Institute for Health Research and was funded by the U-K.
It found that the daily dose increased the likelihood of having no major cardiovascular event, which is a good sign for patients who are already at low risk for heart attacks or strokes.
The results also showed that taking the medication had no effect on the risk for developing certain types of cancer, which could mean that it could be used as a treatment for patients already at high risk for those diseases.
The drug is now in clinical trials in Australia, the U, Brazil and the U of South Africa.
The U.N. agency for global health, the World Health Organization, said in a statement that the drug “is a safe, effective and effective preventive measure for heart attack, stroke and other cardiovascular conditions, including COPD.”
“We are very pleased that COVID drugs can reduce the risk to prevent heart attacks, strokes and related cancers,” Dr. Andrew Wakefield, the British researcher who first discovered the virus, said.
“They can also help prevent and treat other conditions like cancer, but we have to be vigilant and watch what is being done.”
The U. S. government has approved three COVID vaccines that are designed to prevent COVID infections.
They are currently being tested in the United Kingdom and the United States.
study was also conducted in collaboration with the Uppsala University Medical Center, which specializes in the treatment of chronic diseases, including cancer.
The researchers found that taking COVID medications had a statistically significant reduction in heart attack rate.
That means that the medicine prevented a person from having a heart attack in the first place, which, in turn, saved lives.
According to the study, the treatment reduced the risk that a person would die from heart attack by up to 22 percent.
It’s not clear whether the drug was effective in treating the underlying cause of heart attacks in those who were already at risk for it.
The United States is also investigating the possibility that the medication could prevent strokes in people who have already had a stroke.